Status:
COMPLETED
Efficacy of Pulsed Electromagnetic Field Therapy on Acute Radiodermatitis in Breast Cancer Patients
Lead Sponsor:
Ahram Canadian University
Conditions:
Dermatitis, Radiation Induced
Eligibility:
FEMALE
35-55 years
Phase:
NA
Brief Summary
This study aims to evaluate the impact of PEMF on acute radiodermatitis in breast cancer patient and post mastectomy patients.
Detailed Description
The objective is to understand the effect of PEMF on skin thickness and toxicity after radiotherapy on breast cancer. The study included 50 adult female breast cancer undergoing whole-breast irradiat...
Eligibility Criteria
Inclusion
- Breast cancer patients undergoing HF-WBI post-lumpectomy with or without chemotherapy.
- Unilateral breast cancer
- Age from 35-55 years.
Exclusion
- Patients had previous irradiation to the same breast.
- Patients had bilateral breast cancer.
- Patients had metastatic disease.
- when the use of bolus material was required to deliver RT.
- Patients had a pre-existing skin condition or open wound in the treatment area.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06003764
Start Date
November 1 2023
End Date
June 30 2025
Last Update
August 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ahram canadian University
Giza, Egypt